ESMO Targeted Anticancer Therapies Congress 2024
![TAT24_Audience_Session_01](/var/esmo/storage/images/media/esmo-daily-reporter/images/tat2024/live_coverage/tat24_audience_session_01/18875929-2-eng-GB/tat24_audience_session_01_i770.jpg)
Can ctDNA predict outcomes in early phase trials?
Baseline and on-treatment changes in ctDNA may provide an early indication of response to experimental therapies
![TAT2024_Louise_Carter](/var/esmo/storage/images/media/esmo-daily-reporter/images/tat2024/live_coverage/tat2024_louise_carter/18885731-1-eng-GB/tat2024_louise_carter_i770.jpg)
How to predict long-term survival to assess eligibility for phase I trials?
Studies investigate the discriminatory capacity of existing prognostic scales and the factors associated with survival to help select patients who may benefit from participation in early phase trials
![TAT2024_Marcellus_Augustine](/var/esmo/storage/images/media/esmo-daily-reporter/images/tat2024/live_coverage/tat2024_marcellus_augustine/18885737-1-eng-GB/tat2024_marcellus_augustine_i770.jpg)
Machine learning may help to uncover new immunotherapy targets
A study proposes a model that is able to learn broad aspects of cancer–immune interactions from early phase trial data
![Yardena Samuels](/var/esmo/storage/images/media/esmo-daily-reporter/images/portraits/yardena-samuels/14684632-1-eng-GB/yardena-samuels_i770.jpg)
Novel antigens for cancer immunotherapy – a way to enhance effectiveness?
Research is ongoing to revisit the classic neoantigen approach that may better interpret the complexity of the immune system
![Wider implementation of precision oncology is still challenging](/var/esmo/storage/images/esmo-daily-reporter/esmo-targeted-anticancer-therapies-congress-2024/news/wider-implementation-of-precision-oncology-is-still-challenging/18865254-3-eng-GB/wider-implementation-of-precision-oncology-is-still-challenging_i770.jpg)
Wider implementation of precision oncology is still challenging
The 2024 TAT Honorary Awardee Prof. Funda Meric-Bernstam discusses progress made and how to overcome current obstacles in the field